Morgan Stanley Heska Corp Transaction History

Morgan Stanley

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$62.17 - $97.62 $364,378 - $572,150	-5,861 Reduced 2.94%	193,189 $18.9 Million
Q4 2022 Feb 14, 2023	BUY	$60.21 - $77.74 $1.88 Million - $2.43 Million	31,249 Added 18.62%	199,050 $12.4 Million
Q3 2022 Nov 14, 2022	BUY	$72.92 - $99.73 $3.14 Million - $4.3 Million	43,084 Added 34.55%	167,801 $12.2 Million
Q2 2022 Oct 27, 2022	BUY	$84.23 - $147.57 $3.54 Million - $6.21 Million	42,066 Added 50.9%	124,717 $11.8 Million
Q2 2022 Aug 15, 2022	BUY	$84.23 - $147.57 $3.54 Million - $6.21 Million	42,066 Added 50.9%	124,717 $11.8 Million
Q1 2022 Oct 27, 2022	SELL	$122.89 - $171.74 $5.17 Million - $7.22 Million	-42,066 Reduced 33.73%	82,651 $11.4 Million
Q1 2022 May 13, 2022	BUY	$122.89 - $171.74 $3.74 Million - $5.23 Million	30,465 Added 58.38%	82,651 $11.4 Million
Q4 2021 Feb 14, 2022	BUY	$156.0 - $265.78 $1.04 Million - $1.78 Million	6,690 Added 14.7%	52,186 $9.52 Million
Q3 2021 Nov 15, 2021	BUY	$228.69 - $274.2 $10.4 Million - $12.5 Million	45,496 New	45,496 $11.8 Million

26K

Ticker HSKA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,818,900
Description
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.